MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$34,770K
EPS
-$4.04
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
21,185
General and administrative
15,956
Total operating expenses
37,141
Operating loss
-37,141
Impairment charge on investment in equity securities
0
Interest income
2,377
Other expense, net
-6
Loss before income taxes
-34,770
Income taxes benefit
0
Net loss
-34,770
Basic EPS
-4.04
Diluted EPS
-4.04
Basic Average Shares
8,611,321
Diluted Average Shares
8,611,321
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$34,770K Loss before incometaxes-$34,770K Interest income$2,377K Operating loss-$37,141K Other expense, net-$6K Total operatingexpenses$37,141K Research and development$21,185K General andadministrative$15,956K

ATOSSA THERAPEUTICS, INC. (ATOS)

ATOSSA THERAPEUTICS, INC. (ATOS)